ADHD Trial, Recruiting (NCT07595783)

ADHD Trial, Recruiting NCT07595783 Sponsor: Bielefeld University Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT07595783 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children who are between 6 and 13 years old
Children who have been officially diagnosed with ADHD
Children who speak German and have normal vision or vision that is fully corrected with glasses or contact lenses

Who may not be able to join:

Children who have a neurological condition, such as epilepsy
Children who do not have a formal ADHD diagnosis
Children whose parent or guardian is unable to give consent to participate or fill in questionnaires
Children who have taken part in neurofeedback treatment within the past year, or who are currently receiving neurofeedback treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katja Werheid, Prof. Dr., Bielefeld University

Phone: +49 (0) 521 106 67534

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07595783

Sponsor: Bielefeld University

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: +49 (0) 521 106 67534

More information: https://clinicaltrials.gov/study/NCT07595783

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children who are between 6 and 13 years old
Children who have been officially diagnosed with ADHD
Children who speak German and have normal vision or vision that is fully corrected with glasses or contact lenses

Who may not be able to join:

Children who have a neurological condition, such as epilepsy
Children who do not have a formal ADHD diagnosis
Children whose parent or guardian is unable to give consent to participate or fill in questionnaires
Children who have taken part in neurofeedback treatment within the past year, or who are currently receiving neurofeedback treatment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Bielefeld University

Registry

ClinicalTrials.gov

Start date

9 July 2024

Est. completion

31 October 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Adverse effects; Drop-Out rate; Number of included segments; Diagnostic system for mental disorders according to ICD-10 and DSM-5 for children and adolescents - III External report form ADHD specific (DISYPS-III FBB-ADHS; Döpfner et al., 2017); Child Behavior Checklist 6-18/R (CBCL; Döpfner et al., 2014); Teacher Report Form 6-18/R (TRF; Döpfner et al., 2014); Youth Self Report 11-18/R (YSR, Döpfner et al., 2014); Change in central theta and beta activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov